Full Schedule

Type here to filter the list

Friday, March 18, 2022
9:00 AM – 10:45 AM
Session I: Thyroid I
Time Zone: EDT
Faculty: Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center
Faculty: Erik Blomain, MD, PhD – Stanford University
Faculty: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

Favorite

Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center ### 1596869###Faculty###Professor; Director, Thyroid Nodule Clinic###The University of Texas, MD Anderson Cancer Center###
Faculty: Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center
@@@ Erik Blomain, MD, PhD – Stanford University ### 1570630###Faculty###Holman Pathway Research Resident###Stanford University###
Faculty: Erik Blomain, MD, PhD – Stanford University
@@@ Francis P. Worden, MD – University of Michigan/Rogel Cancer Center ### 1589744###Faculty###Professor of Medicine, Division of Hematology/Oncology, Department of Internal Medicine###University of Michigan/Rogel Cancer Center###
Faculty: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center
9:00 AM – 9:05 AM
Welcome and Polling
Time Zone: EDT
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
9:25 AM – 9:45 AM
Novel Uses of Radiation in Thyroid Cancer
Time Zone: EDT
Speaker: Erik Blomain, MD, PhD – Stanford University

Favorite

Erik Blomain, MD, PhD – Stanford University ### 1570630###Speaker###Holman Pathway Research Resident###Stanford University###
Speaker: Erik Blomain, MD, PhD – Stanford University
9:45 AM – 10:10 AM
Case Discussion: Recurrent Follicular Thyroid Cancer
Time Zone: EDT
Moderator: Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center
Panelist: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

Favorite

Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center ### 1596869###Moderator###Professor; Director, Thyroid Nodule Clinic###The University of Texas, MD Anderson Cancer Center###
Moderator: Naifa L. Busaidy, MD, FACE, FACP – The University of Texas, MD Anderson Cancer Center
@@@ Francis P. Worden, MD – University of Michigan/Rogel Cancer Center ### 1589744###Panelist###Professor of Medicine, Division of Hematology/Oncology, Department of Internal Medicine###University of Michigan/Rogel Cancer Center###
Panelist: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center
10:45 AM – 10:55 AM
Break
Time Zone: EDT

Favorite
11:35 AM – 11:45 AM
Break
Time Zone: EDT

Favorite
11:45 AM – 1:10 PM
Session II: Thyroid II
Time Zone: EDT
Faculty: Theresa Guo, MD – University of California, San Diego
Faculty: Mark Zafereo, MD – MD Anderson Cancer Center
Faculty: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

Favorite

Theresa Guo, MD – University of California, San Diego ### 1595310###Faculty###Assistant Professor###University of California, San Diego###
Faculty: Theresa Guo, MD – University of California, San Diego
@@@ Mark Zafereo, MD – MD Anderson Cancer Center ### 1570632###Faculty###Professor###MD Anderson Cancer Center###
Faculty: Mark Zafereo, MD – MD Anderson Cancer Center
@@@ Francis P. Worden, MD – University of Michigan/Rogel Cancer Center ### 1589744###Faculty###Professor of Medicine, Division of Hematology/Oncology, Department of Internal Medicine###University of Michigan/Rogel Cancer Center###
Faculty: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center
12:10 PM – 12:30 PM
State of the Art Anaplastic Thyroid Cancer
Time Zone: EDT
Speaker: Mark Zafereo, MD – MD Anderson Cancer Center

Favorite

Mark Zafereo, MD – MD Anderson Cancer Center ### 1570632###Speaker###Professor###MD Anderson Cancer Center###
Speaker: Mark Zafereo, MD – MD Anderson Cancer Center
12:30 PM – 12:50 PM
Debate: Follicular Thyroid Cancer: VEGF or VEGF + I/O - VEGF
Time Zone: EDT
Debate Speaker: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

Favorite

Francis P. Worden, MD – University of Michigan/Rogel Cancer Center ### 1589744###Debate Speaker###Professor of Medicine, Division of Hematology/Oncology, Department of Internal Medicine###University of Michigan/Rogel Cancer Center###
Debate Speaker: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center
12:50 PM – 1:10 PM
Q&A and Polling
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Theresa Guo, MD – University of California, San Diego
Panelist: Mark Zafereo, MD – MD Anderson Cancer Center
Panelist: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Theresa Guo, MD – University of California, San Diego ### 1595310###Panelist###Assistant Professor###University of California, San Diego###
Panelist: Theresa Guo, MD – University of California, San Diego
@@@ Mark Zafereo, MD – MD Anderson Cancer Center ### 1570632###Panelist###Professor###MD Anderson Cancer Center###
Panelist: Mark Zafereo, MD – MD Anderson Cancer Center
@@@ Francis P. Worden, MD – University of Michigan/Rogel Cancer Center ### 1589744###Panelist###Professor of Medicine, Division of Hematology/Oncology, Department of Internal Medicine###University of Michigan/Rogel Cancer Center###
Panelist: Francis P. Worden, MD – University of Michigan/Rogel Cancer Center
1:10 PM – 1:20 PM
Break
Time Zone: EDT

Favorite
1:20 PM – 2:50 PM
Session III: Sarcomas I
Time Zone: EDT
Faculty: Nam Bui, MD – Stanford University
Faculty: Candace L. Haddox, MD – Dana-Farber Cancer Institute

Favorite

Nam Bui, MD – Stanford University ### 1591250###Faculty###Clinical Assistant Professor###Stanford University###
Faculty: Nam Bui, MD – Stanford University
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Faculty###Instructor in Medicine###Dana-Farber Cancer Institute###
Faculty: Candace L. Haddox, MD – Dana-Farber Cancer Institute
1:20 PM – 1:25 PM
Welcome and Polling
Time Zone: EDT
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
1:55 PM – 2:25 PM
Novel and Targeted Therapies in Soft Tissue Sarcoma
Time Zone: EDT
Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute

Favorite

Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Speaker###Instructor in Medicine###Dana-Farber Cancer Institute###
Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute
2:25 PM – 2:50 PM
Q&A and Polling
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Panelist: Nam Bui, MD – Stanford University

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Panelist###Instructor in Medicine###Dana-Farber Cancer Institute###
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Nam Bui, MD – Stanford University ### 1591250###Panelist###Clinical Assistant Professor###Stanford University###
Panelist: Nam Bui, MD – Stanford University
2:50 PM – 3:00 PM
Break
Time Zone: EDT

Favorite
4:55 PM – 5:00 PM
Concluding Remarks
Time Zone: EDT

Favorite
3:00 PM – 5:00 PM
Session IV: Sarcomas II
Time Zone: EDT
Faculty: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
Faculty: Erik Blomain, MD, PhD – Stanford University
Faculty: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Faculty: Nam Bui, MD – Stanford University
Faculty: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Faculty###Professor of Medicine###Washington University in St. Louis###
Faculty: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
@@@ Erik Blomain, MD, PhD – Stanford University ### 1570630###Faculty###Holman Pathway Research Resident###Stanford University###
Faculty: Erik Blomain, MD, PhD – Stanford University
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Faculty###Instructor in Medicine###Dana-Farber Cancer Institute###
Faculty: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Nam Bui, MD – Stanford University ### 1591250###Faculty###Clinical Assistant Professor###Stanford University###
Faculty: Nam Bui, MD – Stanford University
@@@ Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Faculty###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Faculty: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
3:25 PM – 3:30 PM
Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - DISCUSSION
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Erik Blomain, MD, PhD – Stanford University
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Erik Blomain, MD, PhD – Stanford University ### 1570630###Panelist###Holman Pathway Research Resident###Stanford University###
Panelist: Erik Blomain, MD, PhD – Stanford University
@@@ Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Panelist###Professor of Medicine###Washington University in St. Louis###
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
3:40 PM – 3:50 PM
Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - NO (CHEMOTHERAPY)
Time Zone: EDT
Debate Speaker: Nam Bui, MD – Stanford University

Favorite

Nam Bui, MD – Stanford University ### 1591250###Debate Speaker###Clinical Assistant Professor###Stanford University###
Debate Speaker: Nam Bui, MD – Stanford University
3:55 PM – 4:25 PM
Case Discussion: Management of a Desmoid Tumor
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Nam Bui, MD – Stanford University
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Nam Bui, MD – Stanford University ### 1591250###Panelist###Clinical Assistant Professor###Stanford University###
Panelist: Nam Bui, MD – Stanford University
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Panelist###Instructor in Medicine###Dana-Farber Cancer Institute###
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Panelist###Professor of Medicine###Washington University in St. Louis###
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
Friday, May 6, 2022
1:00 PM – 2:25 PM
Session I: Neuroblastoma I
Time Zone: EDT
Presenter: Susan L. Cohn, MD – University of Chicago Medicine
Session Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
Presenter: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
Presenter: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London

Favorite

Susan L. Cohn, MD – University of Chicago Medicine ### 1614370###Presenter###Director, Clinical Sciences; Professor of Pediatrics###University of Chicago Medicine###
Presenter: Susan L. Cohn, MD – University of Chicago Medicine
@@@ Debra Friedman, MD.MS – Vanderbilt University Medical Center ### 1637089###Session Moderator###Director, Division of Pediatric Hematology and Oncology###Vanderbilt University Medical Center###
Session Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
@@@ Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto ### 1641924###Presenter###Assistant Professor, Department of Paediatrics###The Hospital for Sick Children (SickKids), University of Toronto###
Presenter: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
@@@ Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London ### 1649092###Presenter###Retired Professor of Paediatric Oncology###Institute of Cancer Research, Royal Marsden Hospital, London###
Presenter: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London
1:00 PM – 1:05 PM
Welcome and Polling
Time Zone: EDT
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

Favorite

Debra Friedman, MD.MS – Vanderbilt University Medical Center ### 1637089###Moderator###Director, Division of Pediatric Hematology and Oncology###Vanderbilt University Medical Center###
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
1:05 PM – 1:25 PM
Genomics and Genetics of Neuroblastoma
Time Zone: EDT
Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

Favorite

Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto ### 1641924###Speaker###Assistant Professor, Department of Paediatrics###The Hospital for Sick Children (SickKids), University of Toronto###
Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
1:25 PM – 1:45 PM
New Developments in Relapsed and Refractory Neuroblastoma
Time Zone: EDT
Speaker: Susan L. Cohn, MD – University of Chicago Medicine

Favorite

Susan L. Cohn, MD – University of Chicago Medicine ### 1614370###Speaker###Director, Clinical Sciences; Professor of Pediatrics###University of Chicago Medicine###
Speaker: Susan L. Cohn, MD – University of Chicago Medicine
1:45 PM – 2:05 PM
Treatment for Stage 3 Neuroblastoma in Patients > 18 Months
Time Zone: EDT
Speaker: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London

Favorite

Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London ### 1649092###Speaker###Retired Professor of Paediatric Oncology###Institute of Cancer Research, Royal Marsden Hospital, London###
Speaker: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London
2:05 PM – 2:25 PM
Q&A and Polling
Time Zone: EDT
Panelist: Susan L. Cohn, MD – University of Chicago Medicine
Panelist: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

Favorite

Susan L. Cohn, MD – University of Chicago Medicine ### 1614370###Panelist###Director, Clinical Sciences; Professor of Pediatrics###University of Chicago Medicine###
Panelist: Susan L. Cohn, MD – University of Chicago Medicine
@@@ Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London ### 1649092###Panelist###Retired Professor of Paediatric Oncology###Institute of Cancer Research, Royal Marsden Hospital, London###
Panelist: Andy D. J Pearson, MD – Institute of Cancer Research, Royal Marsden Hospital, London
@@@ Debra Friedman, MD.MS – Vanderbilt University Medical Center ### 1637089###Moderator###Director, Division of Pediatric Hematology and Oncology###Vanderbilt University Medical Center###
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
2:25 PM – 2:35 PM
Break
Time Zone: EDT

Favorite
2:35 PM – 3:35 PM
Non-CME Innovation Theater
Time Zone: EDT

Favorite
3:35 PM – 3:45 PM
Break
Time Zone: EDT

Favorite
3:45 PM – 5:15 PM
Session II: Neuroblastoma II
Time Zone: EDT
Session Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
Presenter: Tara Henderson, MD, MPH – University of Chicago
Presenter: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

Favorite

Debra Friedman, MD.MS – Vanderbilt University Medical Center ### 1637089###Session Moderator###Director, Division of Pediatric Hematology and Oncology###Vanderbilt University Medical Center###
Session Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
@@@ Tara Henderson, MD, MPH – University of Chicago ### 1649254###Presenter###Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation###University of Chicago###
Presenter: Tara Henderson, MD, MPH – University of Chicago
@@@ Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto ### 1641924###Presenter###Assistant Professor, Department of Paediatrics###The Hospital for Sick Children (SickKids), University of Toronto###
Presenter: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
3:45 PM – 3:50 PM
Welcome and Polling
Time Zone: EDT
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Debra Friedman, MD.MS – Vanderbilt University Medical Center ### 1637089###Moderator###Director, Division of Pediatric Hematology and Oncology###Vanderbilt University Medical Center###
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
3:50 PM – 4:10 PM
Managing Toxicity of Neuroblastoma Therapy
Time Zone: EDT
Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

Favorite

Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto ### 1641924###Speaker###Assistant Professor, Department of Paediatrics###The Hospital for Sick Children (SickKids), University of Toronto###
Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
4:10 PM – 4:30 PM
Survivorship in Neuroblastoma Patients
Time Zone: EDT
Speaker: Tara Henderson, MD, MPH – University of Chicago

Favorite

Tara Henderson, MD, MPH – University of Chicago ### 1649254###Speaker###Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation###University of Chicago###
Speaker: Tara Henderson, MD, MPH – University of Chicago
4:30 PM – 4:50 PM
Chemoimmunotherapy as First Line Therapy of Neuroblastoma
Time Zone: EDT
Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto

Favorite

Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto ### 1641924###Speaker###Assistant Professor, Department of Paediatrics###The Hospital for Sick Children (SickKids), University of Toronto###
Speaker: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
4:50 PM – 5:10 PM
Q&A and Polling
Time Zone: EDT
Panelist: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
Panelist: Tara Henderson, MD, MPH – University of Chicago
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

Favorite

Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto ### 1641924###Panelist###Assistant Professor, Department of Paediatrics###The Hospital for Sick Children (SickKids), University of Toronto###
Panelist: Daniel A. Morgenstern, MB BChir PhD – The Hospital for Sick Children (SickKids), University of Toronto
@@@ Tara Henderson, MD, MPH – University of Chicago ### 1649254###Panelist###Chief, Pediatric Hematology, Oncology and Stem Cell Transplantation###University of Chicago###
Panelist: Tara Henderson, MD, MPH – University of Chicago
@@@ Debra Friedman, MD.MS – Vanderbilt University Medical Center ### 1637089###Moderator###Director, Division of Pediatric Hematology and Oncology###Vanderbilt University Medical Center###
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
5:10 PM – 5:15 PM
Concluding Remarks
Time Zone: EDT
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center

Favorite

Debra Friedman, MD.MS – Vanderbilt University Medical Center ### 1637089###Moderator###Director, Division of Pediatric Hematology and Oncology###Vanderbilt University Medical Center###
Moderator: Debra Friedman, MD.MS – Vanderbilt University Medical Center
Friday, June 17, 2022
1:00 PM – 2:35 PM
Session I: WM I
Time Zone: ET
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Presenter: Prashant Kapoor, MD – Mayo Clinic
Presenter: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine
Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Prashant Kapoor, MD – Mayo Clinic ### 694019###Presenter###Associate Professor of Medicine###Mayo Clinic###
Presenter: Prashant Kapoor, MD – Mayo Clinic
@@@ Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine ### 947220###Presenter###Abby and John Friend Professor of Cancer Research###Northwestern University Feinberg School of Medicine###
Presenter: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine
@@@ Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute ### 1666066###Presenter###Member###CBCI- Colorado Blood Cancer Institute###
Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
1:00 PM – 1:05 PM
Welcome and Polling
Time Zone: ET
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
1:05 PM – 1:25 PM
The Genomics of Waldenström Macroglobulinemia
Time Zone: ET
Speaker: Prashant Kapoor, MD – Mayo Clinic

Favorite

Prashant Kapoor, MD – Mayo Clinic ### 694019###Speaker###Associate Professor of Medicine###Mayo Clinic###
Speaker: Prashant Kapoor, MD – Mayo Clinic
1:25 PM – 1:45 PM
Current and Emerging Treatment Options in Waldenström Macroglobulinemia
Time Zone: ET
Speaker: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine

Favorite

Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine ### 947220###Speaker###Abby and John Friend Professor of Cancer Research###Northwestern University Feinberg School of Medicine###
Speaker: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine
1:45 PM – 1:52 PM
Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - BR
Time Zone: ET
Speaker: Prashant Kapoor, MD – Mayo Clinic

Favorite

Prashant Kapoor, MD – Mayo Clinic ### 694019###Speaker###Associate Professor of Medicine ###Mayo Clinic###
Speaker: Prashant Kapoor, MD – Mayo Clinic
1:52 PM – 1:59 PM
Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - BTK
Time Zone: ET
Debate Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

Favorite

Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute ### 1666066###Debate Speaker###Member###CBCI- Colorado Blood Cancer Institute###
Debate Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
1:59 PM – 2:05 PM
Debate: BTK Inhibitors vs Bendamustine-Rituximab (BR) as Primary Therapy - DISCUSSION
Time Zone: ET
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Prashant Kapoor, MD – Mayo Clinic
Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Prashant Kapoor, MD – Mayo Clinic ### 694019###Panelist###Associate Professor of Medicine###Mayo Clinic###
Panelist: Prashant Kapoor, MD – Mayo Clinic
@@@ Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute ### 1666066###Panelist###Member###CBCI- Colorado Blood Cancer Institute###
Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
2:05 PM – 2:35 PM
Q&A and Polling
Time Zone: ET
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine
Panelist: Prashant Kapoor, MD – Mayo Clinic
Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine ### 947220###Panelist###Abby and John Friend Professor of Cancer Research###Northwestern University Feinberg School of Medicine###
Panelist: Leo I. Gordon, MD – Northwestern University Feinberg School of Medicine
@@@ Prashant Kapoor, MD – Mayo Clinic ### 694019###Panelist###Associate Professor of Medicine###Mayo Clinic###
Panelist: Prashant Kapoor, MD – Mayo Clinic
@@@ Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute ### 1666066###Panelist###Member###CBCI- Colorado Blood Cancer Institute###
Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
2:35 PM – 2:55 PM
Break
Time Zone: ET

Favorite
2:55 PM – 4:30 PM
Session II: WM II
Time Zone: ET
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
Presenter: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation
Presenter: Prashant Kapoor, MD – Mayo Clinic
Presenter: Shayna Sarosiek, MD – Dana Farber Cancer Institute

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute ### 1666066###Presenter###Member###CBCI- Colorado Blood Cancer Institute###
Presenter: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
@@@ Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation ### 1678474###Presenter###Community Member###International Waldenstrom’s Macroglobulinemia Foundation###
Presenter: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation
@@@ Prashant Kapoor, MD – Mayo Clinic ### 694019###Presenter###Associate Professor of Medicine###Mayo Clinic###
Presenter: Prashant Kapoor, MD – Mayo Clinic
@@@ Shayna Sarosiek, MD – Dana Farber Cancer Institute ### 1661337###Presenter###Physician###Dana Farber Cancer Institute###
Presenter: Shayna Sarosiek, MD – Dana Farber Cancer Institute
2:55 PM – 3:00 PM
Welcome and Polling
Time Zone: ET
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
3:00 PM – 3:20 PM
Role of BTK inhibitors in Waldenström Macroglobulinemia
Time Zone: ET
Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

Favorite

Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute ### 1666066###Speaker###Member###CBCI- Colorado Blood Cancer Institute###
Speaker: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
3:20 PM – 3:40 PM
Treatment Adherence: A Patient's Perspective
Time Zone: ET
Speaker: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation

Favorite

Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation ### 1678474###Speaker###Community Member###International Waldenstrom’s Macroglobulinemia Foundation###
Speaker: Julie Richardson – International Waldenstrom’s Macroglobulinemia Foundation
3:40 PM – 4:00 PM
Case Discussion: When to Wait and When to Treat
Time Zone: ET
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Prashant Kapoor, MD – Mayo Clinic
Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Prashant Kapoor, MD – Mayo Clinic ### 694019###Panelist###Associate Professor of Medicine###Mayo Clinic###
Panelist: Prashant Kapoor, MD – Mayo Clinic
@@@ Shayna Sarosiek, MD – Dana Farber Cancer Institute ### 1661337###Panelist###Physician###Dana Farber Cancer Institute###
Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute
4:00 PM – 4:30 PM
Q&A and Polling
Time Zone: ET
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Prashant Kapoor, MD – Mayo Clinic
Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute
Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Prashant Kapoor, MD – Mayo Clinic ### 694019###Panelist###Associate Professor of Medicine###Mayo Clinic###
Panelist: Prashant Kapoor, MD – Mayo Clinic
@@@ Shayna Sarosiek, MD – Dana Farber Cancer Institute ### 1661337###Panelist###Physician###Dana Farber Cancer Institute###
Panelist: Shayna Sarosiek, MD – Dana Farber Cancer Institute
@@@ Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute ### 1666066###Panelist###Member###CBCI- Colorado Blood Cancer Institute###
Panelist: Jeffrey Matous, MD – CBCI- Colorado Blood Cancer Institute
Friday, September 16, 2022
9:00 AM – 9:05 AM
Welcome and Polling
Time Zone: EDT
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
9:00 AM – 11:40 AM
Session I: Sarcomas I
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Presenter: Nam Bui, MD – Stanford University
Presenter: Candace L. Haddox, MD – Dana-Farber Cancer Institute

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Nam Bui, MD – Stanford University ### 1591250###Presenter###Clinical Assistant Professor###Stanford University###
Presenter: Nam Bui, MD – Stanford University
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Presenter###Instructor in Medicine###Dana-Farber Cancer Institute###
Presenter: Candace L. Haddox, MD – Dana-Farber Cancer Institute
9:05 AM – 9:35 AM
Classification of Sarcomas
Time Zone: EDT
Speaker: Nam Bui, MD – Stanford University

Favorite

Nam Bui, MD – Stanford University ### 1591250###Speaker###Clinical Assistant Professor###Stanford University###
Speaker: Nam Bui, MD – Stanford University
9:35 AM – 10:00 AM
Novel and Targeted Therapies in Soft Tissue Sarcoma
Time Zone: EDT
Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute

Favorite

Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Speaker###Instructor in Medicine###Dana-Farber Cancer Institute###
Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute
10:00 AM – 10:30 AM
Q&A and Polling
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Panelist: Nam Bui, MD – Stanford University

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Panelist###Instructor in Medicine###Dana-Farber Cancer Institute###
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Nam Bui, MD – Stanford University ### 1591250###Panelist###Clinical Assistant Professor###Stanford University###
Panelist: Nam Bui, MD – Stanford University
10:30 AM – 10:40 AM
Exhibit Hall
Time Zone: EDT

Favorite
10:40 AM – 11:40 AM
Non-CME Innovation Theater (Sponsored by Aadi Bioscience)
Time Zone: EDT

Favorite
11:40 AM – 11:50 AM
Exhibit Hall
Time Zone: EDT

Favorite
1:35 PM – 1:40 PM
Concluding Remarks
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
###
11:50 AM – 1:40 PM
Session II: Sarcomas II
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Presenter: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
Presenter: Erik Blomain, MD, PhD – Stanford University
Presenter: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Presenter: Nam Bui, MD – Stanford University

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Presenter###Professor of Medicine###Washington University in St. Louis###
Presenter: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
@@@ Erik Blomain, MD, PhD – Stanford University ### 1570630###Presenter###Holman Pathway Research Resident###Stanford University###
Presenter: Erik Blomain, MD, PhD – Stanford University
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Presenter###Instructor in Medicine###Dana-Farber Cancer Institute###
Presenter: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Nam Bui, MD – Stanford University ### 1591250###Presenter###Clinical Assistant Professor###Stanford University###
Presenter: Nam Bui, MD – Stanford University
11:50 AM – 11:55 AM
Welcome and Polling
Time Zone: EDT
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Chair###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Chair: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
11:55 AM – 12:02 PM
Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - SURGERY
Time Zone: EDT
Debate Speaker: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

Favorite

Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Debate Speaker###Professor of Medicine###Washington University in St. Louis###
Debate Speaker: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
12:02 PM – 12:10 PM
Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - NEOADJUVANT THERAPY
Time Zone: EDT
Debate Speaker: Erik Blomain, MD, PhD – Stanford University

Favorite

Erik Blomain, MD, PhD – Stanford University ### 1570630###Debate Speaker###Holman Pathway Research Resident###Stanford University###
Debate Speaker: Erik Blomain, MD, PhD – Stanford University
12:10 PM – 12:15 PM
Debate: Management of Retroperitoneal Sarcoma: Surgery Upfront vs Neoadjuvant Therapy - DISCUSSION
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Erik Blomain, MD, PhD – Stanford University
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Erik Blomain, MD, PhD – Stanford University ### 1570630###Panelist###Holman Pathway Research Resident###Stanford University###
Panelist: Erik Blomain, MD, PhD – Stanford University
@@@ Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Panelist###Professor of Medicine###Washington University in St. Louis###
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
12:15 PM – 12:22 PM
Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - YES (I/O)
Time Zone: EDT
Debate Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute

Favorite

Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Debate Speaker###Instructor in Medicine###Dana-Farber Cancer Institute###
Debate Speaker: Candace L. Haddox, MD – Dana-Farber Cancer Institute
12:22 PM – 12:30 PM
Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - NO (CHEMOTHERAPY)
Time Zone: EDT
Debate Speaker: Nam Bui, MD – Stanford University

Favorite

Nam Bui, MD – Stanford University ### 1591250###Debate Speaker###Clinical Assistant Professor###Stanford University###
Debate Speaker: Nam Bui, MD – Stanford University
12:30 PM – 12:35 PM
Debate: Systemic Therapy of Advanced Sarcoma: Is I/O Ready for Prime Time? - DISCUSSION
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Panelist: Nam Bui, MD – Stanford University

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Panelist###Instructor in Medicine###Dana-Farber Cancer Institute###
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Nam Bui, MD – Stanford University ### 1591250###Panelist###Clinical Assistant Professor###Stanford University###
Panelist: Nam Bui, MD – Stanford University
12:35 PM – 1:05 PM
Case Discussion: Management of a Desmoid Tumor
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Nam Bui, MD – Stanford University
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Nam Bui, MD – Stanford University ### 1591250###Panelist###Clinical Assistant Professor###Stanford University###
Panelist: Nam Bui, MD – Stanford University
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Panelist###Instructor in Medicine###Dana-Farber Cancer Institute###
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Panelist###Professor of Medicine###Washington University in St. Louis###
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
1:05 PM – 1:35 PM
Q&A and Polling
Time Zone: EDT
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Panelist: Nam Bui, MD – Stanford University
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
Panelist: Erik Blomain, MD, PhD – Stanford University

Favorite

Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center ### 697513###Moderator###Ingram Professor of Cancer Research###Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center###
Moderator: Jordan D. Berlin, MD – Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
@@@ Nam Bui, MD – Stanford University ### 1591250###Panelist###Clinical Assistant Professor###Stanford University###
Panelist: Nam Bui, MD – Stanford University
@@@ Brian A. Van Tine, MD, PhD – Washington University in St. Louis ### 1598068###Panelist###Professor of Medicine###Washington University in St. Louis###
Panelist: Brian A. Van Tine, MD, PhD – Washington University in St. Louis
@@@ Candace L. Haddox, MD – Dana-Farber Cancer Institute ### 1596643###Panelist###Instructor in Medicine###Dana-Farber Cancer Institute###
Panelist: Candace L. Haddox, MD – Dana-Farber Cancer Institute
@@@ Erik Blomain, MD, PhD – Stanford University ### 1570630###Panelist###Holman Pathway Research Resident###Stanford University###
Panelist: Erik Blomain, MD, PhD – Stanford University